phase readout
saveNCT07358676: A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer
NOT_YET_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE2. Conditions: Small Cell Lung Cancer (SCLC), SCLC, Extensive Stage
view source ↗
comments(0)
5-min edit window · permanent after that